Related references
Note: Only part of the references are listed.CES2, ABCG2, TS and Topo-I Primary and Synchronous Metastasis Expression and Clinical Outcome in Metastatic Colorectal Cancer Patients Treated with First-Line FOLFIRI Regimen
Nicola Silvestris et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
A novel classification of colorectal tumors based on microsatellite instability, the CpG island methylator phenotype and chromosomal instability: implications for prognosis
C. C. J. M. Simons et al.
ANNALS OF ONCOLOGY (2013)
Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer
Vlad Popovici et al.
BMC CANCER (2013)
Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer
Dimitra K. Alexopoulou et al.
CLINICAL BIOCHEMISTRY (2013)
Acquired irinotecan resistance is accompanied by stable modifications of cell cycle dynamics independent of MSI status
Amelie Petitprez et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer
Eva Budinska et al.
JOURNAL OF PATHOLOGY (2013)
High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer
Mads H. Rasmussen et al.
MOLECULAR ONCOLOGY (2013)
A colorectal cancer classification system that associates cellular phenotype and responses to therapy
Anguraj Sadanandam et al.
NATURE MEDICINE (2013)
Keratin23 (KRT23) Knockdown Decreases Proliferation and Affects the DNA Damage Response of Colon Cancer Cells
Karin Birkenkamp-Demtroder et al.
PLOS ONE (2013)
Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior
Beatriz Perez-Villamil et al.
BMC CANCER (2012)
MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling
Sidong Huang et al.
CELL (2012)
Identification of a Poor-Prognosis BRAF-Mutant-Like Population of Patients With Colon Cancer
Vlad Popovici et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Predictive biomarkers with potential of converting conventional chemotherapy to targeted therapy in patients with metastatic colorectal cancer
Niels Frank Jensen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Overexpression of Snail induces epithelial-mesenchymal transition and a cancer stem cell-like phenotype in human colorectal cancer cells
Fan Fan et al.
CANCER MEDICINE (2012)
TRP Channels and Cancer: New Targets for Diagnosis and Chemotherapy
Giorgio Santoni et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2012)
ABC Transporters: Unvalidated Therapeutic Targets in Cancer and the CNS
Robert W. Robey et al.
Anti-Cancer Agents in Medicinal Chemistry (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Inhibitors of Aldo-Keto Reductases AKR1C1-AKR1C4
P. Brozic et al.
CURRENT MEDICINAL CHEMISTRY (2011)
SNAIL Regulates Interleukin-8 Expression, Stem Cell-Like Activity, and Tumorigenicity of Human Colorectal Carcinoma Cells
Wei-Lun Hwang et al.
GASTROENTEROLOGY (2011)
The Emergence of Drug Transporter-Mediated Multidrug Resistance to Cancer Chemotherapy
Chung-Pu Wu et al.
MOLECULAR PHARMACEUTICS (2011)
Epigenetics and colorectal cancer
Victoria Valinluck Lao et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group
Linlin Zhong et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2011)
Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters
M. Saxena et al.
CELL DEATH & DISEASE (2011)
A randomized study comparing short-time infusion of oxaliplatin in combination with capecitabine XELOX30 and chronomodulated XELOX30 as first-line therapy in patients with advanced colorectal cancer
C. Qvortrup et al.
ANNALS OF ONCOLOGY (2010)
Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
Arnaud D. Roth et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
Metastatic Colorectal Cancer: From Improved Survival to Potential Cure
David J. Gallagher et al.
ONCOLOGY (2010)
Genetic polymorphisms in GST genes and survival of colorectal cancer patients treated with chemotherapy
Silvia Funke et al.
PHARMACOGENOMICS (2010)
Steroid Hormone Transforming Aldo-Keto Reductases and Cancer
Trevor M. Penning et al.
STEROID ENZYMES AND CANCER (2009)
Epithelial-mesenchymal transition with expression of SNAI1-induced chemoresistance in colorectal cancer
Hiromitsu Hoshino et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
Yves Pommier
CHEMICAL REVIEWS (2009)
A review on the use of molecular markers of cytotoxic therapy for colorectal cancer, what have we learned?
Miriam Koopman et al.
EUROPEAN JOURNAL OF CANCER (2009)
Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity
Thomas D. Pfister et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
Da Wei Huang et al.
NUCLEIC ACIDS RESEARCH (2009)
Induction of 1C aldoketoreductases and other drug dose-dependent genes upon acquisition of anthracycline resistance
Zachary W. Veitch et al.
PHARMACOGENETICS AND GENOMICS (2009)
Genetic prognostic and predictive markers in colorectal cancer
Axel Walther et al.
NATURE REVIEWS CANCER (2009)
Ankyrin Repeat Domain 1, ANKRD1, a Novel Determinant of Cisplatin Sensitivity Expressed in Ovarian Cancer
Lyndee L. Scurr et al.
CLINICAL CANCER RESEARCH (2008)
Resistance mechanisms to cancer chemotherapy
Kelly Marie Redmond et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Predictive biomarkers of chemotherapy efficacy in colorectal cancer: Results from the UK MRC FOCUS trial
Michael S. Braun et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Topoisomerase levels determine chemotherapy response in vitro and in vivo
Darren J. Burgess et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Inactivation of the anticancer drugs doxorubicin and oracin by aldo-keto reductase (AKR) 1C3
Romana Novotna et al.
TOXICOLOGY LETTERS (2008)
Molecular mechanisms of resistance and toxicity associated with platinating agents
Cara A. Rabik et al.
CANCER TREATMENT REVIEWS (2007)
MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents
Martin Monte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines
Anthony D. Yang et al.
CLINICAL CANCER RESEARCH (2006)
Glutathione S-transferase P1 polymorphism (Ile105Val) predicts cumulative neuropathy in patients receiving oxaliplatin-based chemotherapy
Thierry Lecomte et al.
CLINICAL CANCER RESEARCH (2006)
Mechanisms of cellular resistance to camptothecins
G. L. Beretta et al.
CURRENT MEDICINAL CHEMISTRY (2006)
The role of FAS to ezrin association in FAS-mediated apoptosis
S Fais et al.
APOPTOSIS (2005)
Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy
IT Tai et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer
QY Zhou et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan
J Boyer et al.
CLINICAL CANCER RESEARCH (2004)
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer:: A randomized GERCOR study
C Tournigand et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
AKT involvement in cisplatin chemoresistance of human uterine cancer cells
V Gagnon et al.
GYNECOLOGIC ONCOLOGY (2004)
The NHE1 Na+/H+ exchanger recruits ezrin/radixin/moesin proteins to regulate Akt-dependent cell survival
KL Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A Randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
RM Goldberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Development of a chemoresistant orthotopic human nonsmall cell lung carcinoma model in nude mice -: Analyses of tumor heterogeneity in relation to the immunohistochemical levels of expression of cyclooxygenase-2, ornithine decarboxylase, lung-related resistance protein, prostaglandin E synthetase, and glutathione-S-transferase (GST)-α, GST-μ, and GST-π
A Mathieu et al.
CANCER (2004)
ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases
L Candeil et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Mechanisms of resistance to topoisomerase I-targeting drugs
ZA Rasheed et al.
ONCOGENE (2003)
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias
BM Bolstad et al.
BIOINFORMATICS (2003)
PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification
PD Thomas et al.
NUCLEIC ACIDS RESEARCH (2003)
Inhibition of BCRP-mediated drug efflux by fumitremorgin-type indolyl diketopiperazines
A van Loevezijn et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Share Paper
